These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 19287994)
1. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. Chuaysri C; Thuwajit P; Paupairoj A; Chau-In S; Suthiphongchai T; Thuwajit C Oncol Rep; 2009 Apr; 21(4):957-69. PubMed ID: 19287994 [TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker. Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135 [TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions. Massani M; Stecca T; Fabris L; Caratozzolo E; Ruffolo C; Furlanetto A; Morton S; Cadamuro M; Strazzabosco M; Bassi N Oncol Rep; 2013 Sep; 30(3):1143-8. PubMed ID: 23807641 [TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. Cadamuro M; Nardo G; Indraccolo S; Dall'olmo L; Sambado L; Moserle L; Franceschet I; Colledan M; Massani M; Stecca T; Bassi N; Morton S; Spirli C; Fiorotto R; Fabris L; Strazzabosco M Hepatology; 2013 Sep; 58(3):1042-53. PubMed ID: 23505219 [TBL] [Abstract][Full Text] [Related]
5. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma. Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X Gene; 2019 May; 698():50-60. PubMed ID: 30822475 [TBL] [Abstract][Full Text] [Related]
7. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma. Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells. Thongchot S; Ferraresi A; Vidoni C; Loilome W; Yongvanit P; Namwat N; Isidoro C Cancer Lett; 2018 Aug; 430():160-171. PubMed ID: 29802929 [TBL] [Abstract][Full Text] [Related]
9. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma. Zhang XF; Dong M; Pan YH; Chen JN; Huang XQ; Jin Y; Shao CK Hum Pathol; 2017 Jul; 65():92-100. PubMed ID: 28457731 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma. Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794 [TBL] [Abstract][Full Text] [Related]
11. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma. Sha M; Jeong S; Qiu BJ; Tong Y; Xia L; Xu N; Zhang JJ; Xia Q Cancer Med; 2018 Sep; 7(9):4665-4677. PubMed ID: 30062820 [TBL] [Abstract][Full Text] [Related]
13. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis. Huang Q; Liu L; Liu CH; Shao F; Xie F; Zhang CH; Hu SY Asian Pac J Cancer Prev; 2012; 13(10):5161-5. PubMed ID: 23244128 [TBL] [Abstract][Full Text] [Related]
14. Cholangiocarcinoma Prognosis Varies over Time Depending on Tumor Site and Pathology. Kaneko R; Sato Y; Kobayashi Y J Gastrointestin Liver Dis; 2018 Mar; 27(1):59-66. PubMed ID: 29557416 [TBL] [Abstract][Full Text] [Related]
15. Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma. Matsushima H; Kuroki T; Kitasato A; Adachi T; Tanaka T; Hirabaru M; Hirayama T; Kuroshima N; Hidaka M; Soyama A; Takatsuki M; Kinoshita N; Sano K; Nishida N; Eguchi S Dig Liver Dis; 2015 Dec; 47(12):1067-75. PubMed ID: 26341967 [TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma. Gu MJ; Choi JH J Clin Pathol; 2014 Mar; 67(3):229-34. PubMed ID: 24062361 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763 [TBL] [Abstract][Full Text] [Related]
18. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Sirica AE Nat Rev Gastroenterol Hepatol; 2011 Nov; 9(1):44-54. PubMed ID: 22143274 [TBL] [Abstract][Full Text] [Related]
19. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis. Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142 [TBL] [Abstract][Full Text] [Related]
20. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma. Nakanuma Y; Uchida T; Sato Y; Uesaka K Hum Pathol; 2017 Feb; 60():46-57. PubMed ID: 27984121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]